000			02001 a2200517 4500
005			20250513195331.0
264		0	_c20000105
008			200001s 0 0 eng d
022			_a0009-7330
024	7		_a10.1161/01.res.85.11.985 _2doi
040			_aNLM _beng _cNLM
100	1		_aFukumoto, S
245	0	0	_aDistinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. _h[electronic resource]
260			_bCirculation research _cNov 1999
300			_a985-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCDC2-CDC28 Kinases
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCyclic AMP _xpharmacology
650	0	4	_aCyclic GMP _xanalogs & derivatives
650	0	4	_aCyclin D1 _xantagonists & inhibitors
650	0	4	_aCyclin-Dependent Kinase 2
650	0	4	_aCyclin-Dependent Kinase 4
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclin-Dependent Kinases _xantagonists & inhibitors
650	0	4	_aCyclins _xphysiology
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aHumans
650	0	4	_aMuscle, Smooth, Vascular _xcytology
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins
650	0	4	_aUmbilical Arteries
700	1		_aKoyama, H
700	1		_aHosoi, M
700	1		_aYamakawa, K
700	1		_aTanaka, S
700	1		_aMorii, H
700	1		_aNishizawa, Y
773	0		_tCirculation research _gvol. 85 _gno. 11 _gp. 985-91
856	4	0	_uhttps://doi.org/10.1161/01.res.85.11.985 _zAvailable from publisher's website
999			_c10527790 _d10527790